Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose ADME study of radiolabeled LEE011 in healthy male volunteers
NL-OMON40904Active, not recruiting
- Sponsor
- Novartis
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ribociclib in cancer, sponsored by Novartis. Started Oct 2014; status: active, not recruiting.
02
Drugs
ribociclib
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON40904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40904.